794 related articles for article (PubMed ID: 25284687)
1. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease.
Siepel FJ; Brønnick KS; Booij J; Ravina BM; Lebedev AV; Pereira JB; Grüner R; Aarsland D
Mov Disord; 2014 Dec; 29(14):1802-8. PubMed ID: 25284687
[TBL] [Abstract][Full Text] [Related]
2. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
3. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
Kübler D; Schroll H; Buchert R; Kühn AA
J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
[TBL] [Abstract][Full Text] [Related]
4. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
5. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
[TBL] [Abstract][Full Text] [Related]
6. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
7. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
[TBL] [Abstract][Full Text] [Related]
8. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
[TBL] [Abstract][Full Text] [Related]
9. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
10. Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease.
Rektorova I; Srovnalova H; Kubikova R; Prasek J
Mov Disord; 2008 Aug; 23(11):1580-7. PubMed ID: 18618663
[TBL] [Abstract][Full Text] [Related]
11. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
[TBL] [Abstract][Full Text] [Related]
12. Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study.
Nobili F; Campus C; Arnaldi D; De Carli F; Cabassi G; Brugnolo A; Dessi B; Morbelli S; Sambuceti G; Abbruzzese G; Rodriguez G
Mov Disord; 2010 Jan; 25(1):35-43. PubMed ID: 20058228
[TBL] [Abstract][Full Text] [Related]
13. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
[TBL] [Abstract][Full Text] [Related]
14. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
Song IU; Chung YA; Oh JK; Chung SW
Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
[TBL] [Abstract][Full Text] [Related]
15. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
[TBL] [Abstract][Full Text] [Related]
16. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease.
Eshuis SA; Maguire RP; Leenders KL; Jonkman S; Jager PL
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):200-9. PubMed ID: 16228235
[TBL] [Abstract][Full Text] [Related]
17. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
[TBL] [Abstract][Full Text] [Related]
18. Striatal dopamine transporters and cognitive function in Parkinson's disease.
Stögbauer J; Rosar F; Dillmann U; Faßbender K; Ezziddin S; Spiegel J
Acta Neurol Scand; 2020 Oct; 142(4):385-391. PubMed ID: 32914881
[TBL] [Abstract][Full Text] [Related]
19. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment.
Kim H; Oh M; Oh JS; Moon H; Chung SJ; Lee CS; Kim JS
Nucl Med Commun; 2019 Dec; 40(12):1216-1223. PubMed ID: 31584466
[TBL] [Abstract][Full Text] [Related]
20. DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson's disease: Longitudinal data from the PPMI study.
Koros C; Simitsi AM; Prentakis A; Papagiannakis N; Bougea A; Pachi I; Papadimitriou D; Beratis I; Papageorgiou SG; Stamelou M; Trapali XG; Stefanis L
Parkinsonism Relat Disord; 2020 Aug; 77():36-42. PubMed ID: 32615498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
